Biotechnet Projects 2013-2015 - Funded by the CTI Verified listing

Since its foundation in 2001, Biotechnet has executed over 150 successful projects with industry and other research partners. Here are a few highlights from 2013-2015, financed by the Commission for Technology and Innovation (CTI).

2015

• Entwicklung eines immunresponsiven in vitro 3D in vitro Systems (DermaInf) zur Bestimmung der immunsuppressiven und kollagenstimulierenden Wirkung von kosmetischen Wirkstoffen.
• Skin Layer Detection
• Anti-Fibroblast Activation Protein immunotherapy.
• 3D Gewebemodelle – neue Perspektiven für die Medizin.
• Innovative Biokatalyse – Toolbox für eine nachhaltige biobasierte produktion.
• OilGuard – Oil in Water Monitoring
• Bioprinted kidney model for nephrotoxicity assessment
• Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

2014

• F u. E Projekt : Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies
• R and D project : A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues
• PiFPaF - Pipettiersystem mit Flusssensor und Mikroelement zur passiven Flussregelung
• VALIPLATE - Calorimetric tool for validating the liquid volume dispensed by liquid handling instruments
• F u. E Projekt : New drugs for the treatment of diabetes based on an herbal medicinal product
• Automatisierte Extraktion von Trockenblutproben für das Neugeborenenscreening

2013

• F u. E Projekt : HIT to LEAD to Preclinical Candidate development of a Transcription Repressor Inhibitory Compound (TRIC) that increase antibiotic susceptibility of multidrug resistant staphylococci
• A robust CHO cell-based process platform for rapid manufacture of novel fully human bispecific monoclonal antibodies with importance for preclinical studies, immuno- and cancer therapies
• Prozessoptimierung für die Herstellung eines humanen monoklonalen Antikörpers mittels einer Hybridoma Zelllinie zur Therapie von MRS Infektionen
• Entwicklung einer magnetgelagerten single-use Zentrifugalpumpe für biopharmazeutische Applikationen
• Gepulstes nano Dosierventil mit integriertem Mass Flow Controller
• Entwicklung und Markteinführung eines Marker-freien Affinitätsmessgerätes mit höchster Empfindlichkeit
• Development of a technology platform for a scalable production of therapeutically relevant stem cells